Filing Details

Accession Number:
0001104659-24-105581
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-02 21:55:58
Reporting Period:
2024-10-01
Accepted Time:
2024-10-02 21:55:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1041024 Rockwell Medical Inc. RMTI Pharmaceutical Preparations (2834) 383317208
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2025169 Timothy Chole C/O Rockwell Medical, Inc.
30142 Wixom Road
Wixom MI 48393
Svp, Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-10-01 1,001 $3.69 55,171 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024 in multiple trades at prices ranging from $3.67 to $3.69. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. Due to an administrative error, the withholding of 2,823 shares to cover the estimated tax withholding obligation was erroneously omitted from the Form 3 filed on May 30, 2024. This form reflects the correct amount of common stock beneficially owned by the Reporting Person.